- Home
- SPSC vs NUVL Comparison
SPSC vs NUVL Comparison
Compare SPSC & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPSC
- NUVL
- Stock Information
- Founded
- SPSC 1987
- NUVL 2017
- Country
- SPSC United States
- NUVL United States
- Employees
- SPSC N/A
- NUVL N/A
- Industry
- SPSC EDP Services
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- SPSC Technology
- NUVL Health Care
- Exchange
- SPSC Nasdaq
- NUVL Nasdaq
- Market Cap
- SPSC 5.4B
- NUVL 5.6B
- IPO Year
- SPSC 2010
- NUVL 2021
- Fundamental
- Price
- SPSC $133.47
- NUVL $75.00
- Analyst Decision
- SPSC Strong Buy
- NUVL Strong Buy
- Analyst Count
- SPSC 10
- NUVL 8
- Target Price
- SPSC $195.80
- NUVL $115.50
- AVG Volume (30 Days)
- SPSC 317.0K
- NUVL 452.9K
- Earning Date
- SPSC 07-24-2025
- NUVL 08-07-2025
- Dividend Yield
- SPSC N/A
- NUVL N/A
- EPS Growth
- SPSC 16.96
- NUVL N/A
- EPS
- SPSC 2.14
- NUVL N/A
- Revenue
- SPSC $669,738,000.00
- NUVL N/A
- Revenue This Year
- SPSC $21.65
- NUVL N/A
- Revenue Next Year
- SPSC $12.77
- NUVL N/A
- P/E Ratio
- SPSC $62.39
- NUVL N/A
- Revenue Growth
- SPSC 19.46
- NUVL N/A
- 52 Week Low
- SPSC $120.09
- NUVL $55.54
- 52 Week High
- SPSC $218.61
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- SPSC 38.42
- NUVL 48.73
- Support Level
- SPSC $132.60
- NUVL $76.42
- Resistance Level
- SPSC $145.00
- NUVL $78.94
- Average True Range (ATR)
- SPSC 3.90
- NUVL 2.71
- MACD
- SPSC -1.09
- NUVL -0.34
- Stochastic Oscillator
- SPSC 5.80
- NUVL 31.73
About SPSC SPS Commerce Inc.
SPS Commerce Inc is a provider of cloud-based supply chain management services for retailers, grocers, distributors, suppliers, and logistics firms to increase supply chain performance, optimize inventory levels and sell-through, reduce operational costs, improve order visibility, and satisfy consumer demands for a seamless omnichannel experience. Its solutions are delivered through the SPS Commerce platform and provide integrations and retail performance analytics to its customers. Its products are; Fulfillment, Analytics, and Other products like Assortment and Community also it provides one-time services such as professional services and testing and certification. The group derives revenue from subscription-based recurring revenue services.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.